Literature DB >> 15738491

Reason and rights in global drug control policy.

Richard Elliott1, Joanne Csete, Anita Palepu, Thomas Kerr.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15738491      PMCID： PMC550636          DOI： 10.1503/cmaj.050115

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  13 in total

Review 1.  Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world.

Authors:  Evan Wood; Julio S G Montaner; David R Bangsberg; Mark W Tyndall; Steffanie A Strathdee; Michael V O'Shaughnessy; Robert S Hogg
Journal:  AIDS       Date:  2003-11-21       Impact factor: 4.177

2.  AIDS epidemic update: December 1999.

Authors: 
Journal:  AIDS Anal Afr       Date:  2000 Feb-Mar

3.  HIV in injecting drug users in Asian countries.

Authors:  Alex Wodak; Robert Ali; Michael Farrell
Journal:  BMJ       Date:  2004-09-25

4.  Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group.

Authors:  J P Moatti; M P Carrieri; B Spire; J A Gastaut; J P Cassuto; J Moreau
Journal:  AIDS       Date:  2000-01-28       Impact factor: 4.177

5.  Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users.

Authors:  Barbara J Turner; Christine Laine; Leon Cosler; Walter W Hauck
Journal:  J Gen Intern Med       Date:  2003-04       Impact factor: 5.128

6.  Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users.

Authors:  D D Celentano; N Galai; A K Sethi; N G Shah; S A Strathdee; D Vlahov; J E Gallant
Journal:  AIDS       Date:  2001-09-07       Impact factor: 4.177

Review 7.  Substitution treatment of injecting opioid users for prevention of HIV infection.

Authors:  L Gowing; M Farrell; R Bornemann; R Ali
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

8.  Global overview of injecting drug use and HIV infection among injecting drug users.

Authors:  Carmen Aceijas; Gerry V Stimson; Matthew Hickman; Tim Rhodes
Journal:  AIDS       Date:  2004-11-19       Impact factor: 4.177

9.  Adherence to zidovudine (AZT) among HIV-infected methadone patients: a pilot study of supervised therapy and dispensing compared to usual care.

Authors:  T L Wall; J L Sorensen; S L Batki; K L Delucchi; J A London; M A Chesney
Journal:  Drug Alcohol Depend       Date:  1995-03       Impact factor: 4.492

10.  Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment.

Authors:  Anita Palepu; Nicholas J Horton; Nicole Tibbetts; Seville Meli; Jeffrey H Samet
Journal:  Addiction       Date:  2004-03       Impact factor: 6.526
View more
  3 in total

1.  HIV, harm reduction and human rights.

Authors: 
Journal:  CMAJ       Date:  2005-03-01       Impact factor: 8.262

2.  Evaluating the impact of Mexico's drug policy reforms on people who inject drugs in Tijuana, B.C., Mexico, and San Diego, CA, United States: a binational mixed methods research agenda.

Authors:  Angela M Robertson; Richard S Garfein; Karla D Wagner; Sanjay R Mehta; Carlos Magis-Rodriguez; Jazmine Cuevas-Mota; Patricia Gonzalez Moreno-Zuniga; Steffanie A Strathdee
Journal:  Harm Reduct J       Date:  2014-02-12

3.  Differences in Gut Microbial Diversity are Driven by Drug Use and Drug Cessation by Either Compulsory Detention or Methadone Maintenance Treatment.

Authors:  Qiaoyan Li; Siqi Chen; Ke Liu; Danfeng Long; Diru Liu; Zhengchao Jing; Xiaodan Huang
Journal:  Microorganisms       Date:  2020-03-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.